Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, March 29, 2024 · 699,677,210 Articles · 3+ Million Readers

Global Markets for Blood Plasma Products, 2015-2017 & 2021

Dublin, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The "Global Markets for Blood Plasma Products" report has been added to Research and Markets' offering.

The Global Market for Blood Plasma Reached $16.8 Billion in 2016 and Should Reach $23.0 Billion in 2021, growing at a CAGR of 6.6%

Report Includes

  • An overview of the global markets for blood plasma products.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Analysis of the market by product, application, mode of delivery and by end user.
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products.
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion.
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education.
  • Profiles of major players in the industry.

This research report presents an in-depth analysis of the global blood plasma market by application, product category, mode of delivery, end user and geographic market. The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. The report also features an in-depth analysis of key companies operating in the global blood plasma market and patents that highlight past, current and projected global technology trends.

The blood plasma market is primarily segmented into five major blood plasma components: immunoglobulin, albumin, hyperimmunes, coagulation factors, and other plasma fractionation products. Immunoglobulins are further segmented into intravenous immunoglobulins, subcutaneous immunoglobulins and normal immunoglobulins such as immunoglobulin A (IgA), immunoglobin D (IgD), immunoglobin E (IgE), immunoglobin G (IgG), and immunoglobin M (IgM).

The global blood plasma market is further segmented by application which helps in understanding the potency of blood plasma products in several therapeutic treatments. Products based on these applications are explored in detail and their influence on R&D is examined.

Companies profiled in this report include Grifols S. A., Octopharma AG, Biotest AG, Shire, CSL Ltd., Kedrion S.p.A., China Biologic Products, Sanquin, and others.

Key Topics Covered:

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Geographic Breakdown

2: Summary and Highlights

3: Market and Technology Background

  • Blood Donation
  • Components of Blood Plasma
  • Functions of Blood Plasma
  • Government Funding of Blood Donation Facilities
  • FDA, International Regulatory Agencies and Medical Associations
  • Clinical Guidelines
  • Technology Trends
  • Market Dynamics

4: Market Breakdown by Product Type

  • Immunoglobulins
  • Albumin
  • Hyperimmunes
  • Coagulation Factor Concentrates
  • Other Plasma Fractionation Products

5: Market Breakdown by End User

  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions

6: Market Breakdown by Application

  • Immunology
  • Oncology
  • Pulmonology
  • Rheumatology
  • Transplant
  • Neurology
  • Hematology
  • Others

7: Market Breakdown by Mode of Delivery

  • Infusion Solutions
  • Gels
  • Sprays
  • Biomedical Sealants

8: Market Breakdown by Region

9: Patent Review of Blood Plasma Products

  • Patent Analysis

10: Analysis of Market Opportunities

11: Company Profiles

  • ADMA Biologics Inc.
  • Arthrex Inc.
  • Baxter International
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • Cerus Corp.
  • China Biologic Products Inc.
  • CSL Ltd.
  • General Electric Co.
  • Grifols International S.A.
  • Innovative Research
  • Intas Pharmaceuticals Ltd.
  • Kedrion SPA
  • LFB SA
  • Octopharma AG
  • Prime Biologics
  • Sanquin
  • Shanghai Raas
  • Shire Plc
  • TCS Biosciences Ltd.

12: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/5pxlgr/global_markets


                    
                    
                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: Hematology 
                    

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release